The proposed centre will operate within Abu Dhabi’s Health, Endurance, Longevity, and Medicine (HELM) Cluster, a strategic life sciences platform that integrates research, healthcare delivery, investment, commercialization, and biomanufacturing.
Unlike conventional EHR systems that add AI as an extra feature, IntelliCare places artificial intelligence at the centre of the clinical workflow.
This broader licence gives AviadoBio the flexibility to explore new development pathways and external collaborations while continuing to advance its central nervous system pipeline.
Through the collaboration, the two companies aim to help healthcare providers improve efficiency, streamline operations, and enhance the quality of care delivered to patients.
The African Pooled Procurement Mechanism, led by the Africa Centres for Disease Control and Prevention, is designed to help Member States aggregate demand for medicines, vaccines, diagnostics, and other essential medical supplies.
Under this agreement, CellSave Arabia will act as the exclusive provider of cord blood, cord tissue, placental tissue, cord vessel, and amnion preservation services.
The agreement was formalised during a signing ceremony held at ADCAN Pharma’s advanced manufacturing facility in Abu Dhabi, bringing together senior leadership from both organisations and key healthcare stakeholders.
Under the new agreement, EDE and Novo Nordisk will work together to enhance pharmaceutical supply chain security by increasing in-country value creation and expanding strategic partnerships that help maintain a steady supply of medicines.
The alliance positions WellSpan as a key innovation partner for Philips, enabling the two institutions to co-develop and validate new digital health tools in real-world clinical environments.
Under the agreement, EGT will oversee the rollout of Koios DS™ Breast and Koios DS™ Thyroid across key GCC markets, including the United Arab Emirates, Saudi Arabia, and Qatar.